Alice Chen has 20+ years of research experience in developmental biology, stem cell biology, and tissue engineering. She founded Trestle Biotherapeutics to develop therapeutic tissue for chronic kidney disease treatment.
Intro paths
YC
Alice went through Y Combinator (Winter 2021) — any YC alum in your network can reach them through the YC community.
→
In turn, Alice can intro founders to Trestle Biotherapeutics's investors below.
Trestle Biotherapeutics's investors · 1
Co-founders
Ben Shepherd· FounderBen Shepherd, PhD· CEOAlice Chen, PhD